Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor

Journal of Investigative Dermatology

Volumn 128, Issue 12, 2008, Pages 2783-2791

  Gschwandtner, Maria ^a   Purwar, Rahul ^a   Wittmann, Miriam ^a   Bäumer, Wolfgang ^b   Kietzmann, Manfred ^b   Werfel, Thomas ^a   Gutzmer, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLEMASTINE; GELATINASE B; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR AGONIST; HISTAMINE H2 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H4 RECEPTOR;

ALLERGY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; KERATINOCYTE; PRIORITY JOURNAL; PUNCH BIOPSY; RECEPTOR UPREGULATION; T LYMPHOCYTE;

CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HISTAMINE; HUMANS; IMMUNOHISTOCHEMISTRY; JURKAT CELLS; KERATINOCYTES; MATRIX METALLOPROTEINASE 9; MODELS, BIOLOGICAL; RECEPTORS, HISTAMINE H1; SKIN; T-LYMPHOCYTES; TIME FACTORS;

EID: 57349182713     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.153     Document Type: Article

References (50)

1. Agren MS, Mirastschijski U, Karlsmark T, Saarialho-Kere UK (2001) Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp Dermatol 10:337-48
2. Aoudjit F, Masure S, Opdenakker G, Potworowski EF, St Pierre Y (1999) Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma. Int J Cancer 82:743-7
3. Asano K, Kanai KI, Suzaki H (2004) Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro. Clin Exp Allergy 34:1890-8
4. Atkinson JJ, Senior RM (2003) Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 28:12-24
5. Bachmeier BE, Boukamp P, Lichtinghagen R, Fusenig NE, Fink E (2000a) Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol Chem 381:497-507
6. Bachmeier BE, Nerlich AG, Boukamp P, Lichtinghagen R, Tschesche H, Fritz H et al. (2000b) Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1. Biol Chem 381:509-16
7. Bakker RA, Timmerman H, Leurs R (2002) Histamine receptors: specific ligands, receptor biochemistry, and signal transduction. Clin Allergy Immunol 17:27-64
8. Bannikov GA, Karelina TV, Collier IE, Marmer BL, Goldberg GI (2002) Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J Biol Chem 277:16022-7
9. Birkedal-Hansen H (1995) Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-35
10. Dijkstra D, Leurs R, Chazot P, Shenton FC, Stark H, Werfel T et al. (2007) Histamine downregulates monocyte CCL2 production through the histamine H(4) receptor. J Allergy Clin Immunol 120:300-7
11. Fridman R, Toth M, Chvyrkova I, Meroueh SO, Mobashery S (2003) Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 22:153-66
12. Fridman R, Toth M, Pena D, Mobashery S (1995) Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548-55
13. Giannelli G, Foti C, Marinosci F, Bonamonte D, Antonaci S, Angelini G (2002) Gelatinase expression at positive patch test reactions. Contact Dermatitis 46:280-5
14. Giustizieri ML, Albanesi C, Fluhr J, Gisondi P, Norgauer J, Girolomoni G (2004) H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 114:1176-82
15. Goetzl EJ, Banda MJ, Leppert D (1996) Matrix metalloproteinases in immunity. J Immunol 156:1-4
16. Greenlee KJ, Corry DB, Engler DA, Matsunami RK, Tessier P, Cook RG et al. (2006) Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J Immunol 177:7312-21
17. Groneberg DA, Bester C, Grutzkau A, Serowka F, Fischer A, Henz BM et al. (2005) Mast cells and vasculature in atopic dermatitis -potential stimulus of neoangiogenesis. Allergy 60:90-7
18. Gutzmer R, Diestel C, Mommert S, Kother B, Stark H, Wittmann M et al. (2005) Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Immunol 174:5224-32
19. Gutzmer R, Langer K, Lisewski M, Mommert S, Rieckborn D, Kapp A et al. (2002) Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. J Allergy Clin Immunol 109:524-31
20. Han YP, Tuan TL, Hughes M, Wu H, Garner WL (2001) Transforming growth factor-beta - and tumor necrosis factor-alpha-mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem 276:22341-50
21. Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J et al. (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413:420-5
22. Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H (1999) Human mast cells produce matrix metalloproteinase 9. Eur J Immunol 29:2645-9
23. Kanda N, Watanabe S (2003) Histamine enhances the production of nerve growth factor in human keratinocytes. J Invest Dermatol 121:570-7
24. Kanda N, Watanabe S (2004) Histamine enhances the production of granulocyte-macrophage colony-stimulating factor via protein kinase Calpha and extracellular signal-regulated kinase in human keratinocytes. J Invest Dermatol 122:863-72
25. Kelly EA, Busse WW, Jarjour NN (2000) Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 162:1157-61
26. Kitbunnadaj R, Hashimoto T, Poli E, Zuiderveld OP, Menozzi A, Hidaka R et al. (2005) N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist. J Med Chem 48:2100-7
27. Knauper V, Smith B, Lopez-Otin C, Murphy G (1997) Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem 248:369-73
28. Kobayashi T (2005) MMP-9 and TIMP-1 assays in keratinocyte cultures. Methods Mol Biol 289:201-8
29. Kohda F, Koga T, Uchi H, Urabe K, Furue M (2002) Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-gamma and IL-4 in human keratinocytes. J Dermatol Sci 28:34-41
30. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL (1995) T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154:4379-89
31. Leurs R, Church MK, Taglialatela M (2002) H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 32:489-98
32. Leurs R, Smit MJ, Timmerman H (1995) Molecular pharmacological aspects of histamine receptors. Pharmacol Ther 66:413-63
33. Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R (2005) Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 314:1310-21
34. Liu Z, Zhou X, Shapiro SD, Shipley JM, Twining SS, Diaz LA et al. (2000) The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 102:647-55
35. Lyons JG, Birkedal-Hansen B, Pierson MC, Whitelock JM, Birkedal-Hansen H (1993) Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of M(r) 95 000 type IV collagenase/ gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J Biol Chem 268:19143-51
36. Mohan R, Chintala SK, Jung JC, Villar WV, McCabe F, Russo LA et al. (2002) Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem 277:2065-72
37. Nold M, Goede A, Eberhardt W, Pfeilschifter J, Muhl H (2003) IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10. Naunyn Schmiedebergs Arch Pharmacol 367:68-75
38. Ogata Y, Enghild JJ, Nagase H (1992) Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267:3581-4
39. Onoue S, Kobayashi T, Takemoto Y, Sasaki I, Shinkai H (2003) Induction of matrix metalloproteinase-9 secretion from human keratinocytes in culture by ultraviolet B irradiation. J Dermatol Sci 33:105-11
40. Purwar R, Kraus M, Werfel T, Wittmann M (2008) Modulation of keratinocyte-derived MMP-9 by IL-13: A possible role for the pathogenesis of epidermal inflammation. J Invest Dermatol 128:59-66
41. Ratzinger G, Stoitzner P, Ebner S, Lutz MB, Layton GT, Rainer C et al. (2002) Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol 168:4361-71
42. Sachs B, Hertl M, Merk HF (2000) Histamine receptors on lymphocytes: distribution and functional significance. Skin Pharmacol Appl Skin Physiol 13:313-23
43. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H (1991) Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 266:11436-41
44. Schwingshackl A, Duszyk M, Brown N, Moqbel R (1999) Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J Allergy Clin Immunol 104:983-9
45. Suomela S, Kariniemi AL, Snellman E, Saarialho-Kere U (2001) Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions. Exp Dermatol 10:175-83
46. von Bredow DC, Cress AE, Howard EW, Bowden GT, Nagle RB (1998) Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin. Biochem J 331(Part 3):965-72
47. Wang B, Feliciani C, Freed I, Cai Q, Sauder DN (2001) Insights into molecular mechanisms of contact hypersensitivity gained from gene knockout studies. J Leukoc Biol 70:185-91
48. Wang M, Qin X, Mudgett JS, Ferguson TA, Senior RM, Welgus HG (1999) Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci USA 96:6885-9
49. Wenzel SE, Balzar S, Cundall M, Chu HW (2003) Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol 111:1345-52
50. Wittmann M, Purwar R, Hartmann C, Gutzmer R, Werfel T (2005) Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases. J Invest Dermatol 124:1225-33